RSCH Stock Overview
Operates in the private hospital business in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
PT Charlie Hospital Semarang Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp336.00 |
| 52 Week High | Rp410.00 |
| 52 Week Low | Rp116.00 |
| Beta | 0 |
| 11 Month Change | -12.50% |
| 3 Month Change | 11.26% |
| 1 Year Change | 170.97% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 156.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| RSCH | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | -6.1% | -3.1% | -2.2% |
| 1Y | 171.0% | 19.3% | 9.3% |
Return vs Industry: RSCH exceeded the ID Healthcare industry which returned 19.3% over the past year.
Return vs Market: RSCH exceeded the ID Market which returned 9.3% over the past year.
Price Volatility
| RSCH volatility | |
|---|---|
| RSCH Average Weekly Movement | 6.9% |
| Healthcare Industry Average Movement | 5.8% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in ID Market | 12.6% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: RSCH has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: RSCH's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 216 | H. Junianto | charliehospital.co.id |
PT Charlie Hospital Semarang Tbk operates in the private hospital business in Indonesia. It offers medical services and support, inpatient, and medical check-up services, as well as operates wellness center. The company was founded in 2019 and is based in Kendal, Indonesia.
PT Charlie Hospital Semarang Tbk Fundamentals Summary
| RSCH fundamental statistics | |
|---|---|
| Market cap | Rp890.40b |
| Earnings (TTM) | -Rp524.98m |
| Revenue (TTM) | Rp47.74b |
18.7x
P/S Ratio-1,696x
P/E RatioIs RSCH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RSCH income statement (TTM) | |
|---|---|
| Revenue | Rp47.74b |
| Cost of Revenue | Rp33.16b |
| Gross Profit | Rp14.57b |
| Other Expenses | Rp15.10b |
| Earnings | -Rp524.98m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 30.53% |
| Net Profit Margin | -1.10% |
| Debt/Equity Ratio | 26.6% |
How did RSCH perform over the long term?
See historical performance and comparison